X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12991) 12991
Publication (595) 595
Newsletter (424) 424
Book Review (109) 109
Book Chapter (63) 63
Magazine Article (52) 52
Dissertation (21) 21
Conference Proceeding (16) 16
Newspaper Article (15) 15
Data Set (5) 5
Trade Publication Article (5) 5
Paper (3) 3
Reference (3) 3
Book / eBook (2) 2
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8384) 8384
amiodarone (6842) 6842
male (5198) 5198
female (4122) 4122
amiodarone - therapeutic use (3539) 3539
middle aged (3442) 3442
aged (3248) 3248
amiodarone - adverse effects (3055) 3055
cardiac & cardiovascular systems (2872) 2872
anti-arrhythmia agents - therapeutic use (2564) 2564
index medicus (2381) 2381
adult (1847) 1847
atrial fibrillation (1660) 1660
animals (1653) 1653
anti-arrhythmia agents - adverse effects (1639) 1639
amiodarone - administration & dosage (1560) 1560
atrial fibrillation - drug therapy (1376) 1376
amiodarone - pharmacology (1336) 1336
electrocardiography (1313) 1313
pharmacology & pharmacy (1268) 1268
treatment outcome (1153) 1153
risk factors (1007) 1007
therapy (998) 998
arrhythmias, cardiac - drug therapy (975) 975
anti-arrhythmia agents - administration & dosage (969) 969
medicine, general & internal (892) 892
mortality (850) 850
time factors (831) 831
amiodarone - analogs & derivatives (757) 757
follow-up studies (737) 737
aged, 80 and over (695) 695
arrhythmia (683) 683
drug therapy (683) 683
prevention (683) 683
arrhythmias (676) 676
care and treatment (644) 644
anti-arrhythmia agents - pharmacology (642) 642
rats (622) 622
dose-response relationship, drug (621) 621
retrospective studies (584) 584
heart (578) 578
cardiac arrhythmia (567) 567
tachycardia (561) 561
defibrillators, implantable (543) 543
efficacy (539) 539
myocardial-infarction (538) 538
sinus rhythm (529) 529
research (527) 527
management (524) 524
atrial fibrillation - physiopathology (523) 523
analysis (520) 520
prospective studies (504) 504
heart rate - drug effects (498) 498
heart failure (496) 496
drug interactions (484) 484
recurrence (473) 473
tachycardia - drug therapy (465) 465
atrial-fibrillation (460) 460
medicine & public health (457) 457
intravenous amiodarone (455) 455
atrial fibrillation - therapy (450) 450
drug therapy, combination (449) 449
drugs (447) 447
surgery (447) 447
electric countershock (444) 444
adrenergic beta-antagonists - therapeutic use (439) 439
electrophysiology (424) 424
adolescent (423) 423
prognosis (410) 410
cardiology (408) 408
risk (408) 408
benzofurans - adverse effects (402) 402
tachycardia, ventricular - drug therapy (402) 402
administration, oral (396) 396
complications and side effects (395) 395
fibrillation (390) 390
benzofurans - therapeutic use (385) 385
cardiac patients (385) 385
health aspects (383) 383
abridged index medicus (382) 382
ventricular tachycardia (371) 371
atrial fibrillation - etiology (366) 366
respiratory system (365) 365
antiarrhythmic drugs (358) 358
atrial fibrillation - prevention & control (358) 358
heart-failure (358) 358
amiodarone - pharmacokinetics (347) 347
anti-arrhythmia drugs (347) 347
dosage and administration (347) 347
cardiovascular (343) 343
death, sudden, cardiac - prevention & control (336) 336
sotalol (333) 333
dogs (331) 331
trial (329) 329
catheter ablation (328) 328
infusions, intravenous (327) 327
dronedarone (325) 325
toxicity (325) 325
amiodarone - blood (319) 319
disease (317) 317
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11258) 11258
French (495) 495
German (456) 456
Spanish (298) 298
Russian (242) 242
Italian (226) 226
Japanese (125) 125
Polish (96) 96
Portuguese (95) 95
Chinese (81) 81
Korean (35) 35
Czech (29) 29
Hungarian (24) 24
Turkish (21) 21
Danish (14) 14
Dutch (13) 13
Hebrew (12) 12
Finnish (10) 10
Swedish (8) 8
Romanian (7) 7
Bulgarian (6) 6
Croatian (6) 6
Serbian (6) 6
Norwegian (5) 5
Lithuanian (4) 4
Persian (4) 4
Slovak (4) 4
Icelandic (2) 2
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


L'Endocrinologo, ISSN 1590-170X, 05/2019, Volume 20, Issue S1, pp. 46 - 47
Journal Article
Deutsches Arzteblatt international, 04/2018, Volume 115, Issue 17, p. 297
Journal Article
Toxicological Sciences, ISSN 1096-6080, 01/2011, Volume 120, Issue 1, pp. 98 - 108
Phospholipidosis (PL), a disorder characterized by an accumulation of phospholipids in lysosome-derived multilamellar vesicles owing to abnormal lipid... 
Amiodarone
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 11/2010, Volume 145, Issue 1, pp. 61 - 64
A male newborn weighing 2334 g was delivered at 37 weeks of gestation by caesarean section because of prenatal ultrasound findings of fetal hydrops with... 
Amiodarone
Journal Article
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 04/2016, Volume 133, Issue 17, pp. 1637 - 1644
Journal Article
Biophysical Journal, ISSN 0006-3495, 02/2016, Volume 110, Issue 3, pp. 113a - 113a
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 24, pp. 2268 - 2276
Patients with permanent atrial fibrillation and additional cardiac risk factors were randomly assigned to receive either dronedarone or placebo. At a median of... 
HEART | ARRHYTHMIAS | MORTALITY | ADRENOCEPTOR | MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | SR-33589 | AMIODARONE-LIKE AGENT | Follow-Up Studies | Humans | Anti-Arrhythmia Agents - blood | Hospitalization - statistics & numerical data | Male | Amiodarone - adverse effects | Heart Rate - drug effects | Stroke - chemically induced | Amiodarone - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Drug Therapy, Combination | Digoxin - blood | Digoxin - therapeutic use | Heart Failure - epidemiology | Double-Blind Method | Atrial Fibrillation - drug therapy | Risk Factors | Anti-Arrhythmia Agents - therapeutic use | Amiodarone - analogs & derivatives | Atrial Fibrillation - blood | Anti-Arrhythmia Agents - adverse effects | Atrial Flutter - drug therapy | Aged | Cardiovascular Diseases - chemically induced | Chronic Disease | Heart Failure - chemically induced | Drugs | Product/Service Evaluations | Drug therapy | Atrial fibrillation | Heart failure | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Medical research | Arrhythmia | Risk groups | Cardiovascular disease | Hospitalization | Embolism | Risk factors | Heart rate | Sinuses | Fibrillation | Death | Blood pressure | Ventricle | Acute coronary syndromes | Heart diseases | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 02/2015, Volume 43, Issue 2, pp. 182 - 189
Evaluation of drug-drug interaction (DDI) involving circulating inhibitory metabolites of perpetrator drugs has recently drawn more attention from regulatory... 
IN-VITRO | WARFARIN | KINETICS | HUMANS | PHARMACOLOGY & PHARMACY | PLASMA-PROTEIN BINDING | DESETHYLAMIODARONE | DISCOVERY | DIALYSIS | Cytochrome P-450 CYP2D6 Inhibitors - chemistry | Liver - enzymology | Cytochrome P-450 CYP2D6 Inhibitors - metabolism | Expert Systems | Humans | Middle Aged | Cytochrome P-450 CYP3A Inhibitors - pharmacokinetics | Male | Cytochrome P-450 CYP2C9 Inhibitors - chemistry | Amiodarone - blood | Anti-Arrhythmia Agents - metabolism | Amiodarone - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Drug Interactions | Liver - drug effects | Amiodarone - pharmacokinetics | Computer Simulation | Cytochrome P-450 CYP3A Inhibitors - chemistry | Cytochrome P-450 CYP2C9 Inhibitors - metabolism | Adult | Female | Cytochrome P-450 CYP2C9 Inhibitors - blood | Reproducibility of Results | Cytochrome P-450 CYP2D6 Inhibitors - pharmacokinetics | Cytochrome P-450 CYP3A Inhibitors - blood | Administration, Oral | Liver - metabolism | Amiodarone - antagonists & inhibitors | Anti-Arrhythmia Agents - chemistry | Anti-Arrhythmia Agents - pharmacokinetics | Anti-Arrhythmia Agents - administration & dosage | Amiodarone - analogs & derivatives | Amiodarone - metabolism | Cytochrome P-450 CYP3A Inhibitors - metabolism | Models, Biological | Biotransformation - drug effects | Cytochrome P-450 CYP2D6 Inhibitors - blood | Infusions, Intravenous | Cytochrome P-450 CYP2C9 Inhibitors - pharmacokinetics
Journal Article